Influence of Pilocarpine Eyedrops on the Ocular Biometric Parameters and Intraocular Lens Power Calculation

Table 3

Influence of pilocarpine eyedrops on IOL power calculated using five formulas in PACG patients and normal subjects.

Formulas	Group	Baseline	After eyedrops	Mean difference ± SD	95% CI for mean difference	values
BU II	PACG	22.56 ± 2.03	22.56 ± 2.05	0.00 ± 0.20	−0.08, 0.09	0.940
	Control	22.64 ± 1.49	22.63 ± 1.50	−0.01 ± 0.17	−0.10, 0.09	0.833
Haigis	PACG	22.72 ± 2.14	22.74 ± 2.13	0.01 ± 0.21	−0.08, 0.11	0.745
	Control	22.69 ± 1.42	22.71 ± 1.44	0.02 ± 0.16	−0.08, 0.11	0.724
Hoffer Q	PACG	23.07 ± 2.26	23.10 ± 2.28	0.03 ± 0.20	−0.06, 0.12	0.474
	Control	22.89 ± 1.57	22.92 ± 1.59	0.03 ± 0.16	−0.06, 0.12	0.427
Holladay I	PACG	23.00 ± 2.10	23.02 ± 2.14	0.02 ± 0.22	−0.08, 0.12	0.670
	Control	22.85 ± 1.47	22.88 ± 1.49	0.03 ± 0.15	−0.05, 0.15	0.439
SRK/T	PACG	22.91 ± 2.03	22.95 ± 2.06	0.04 ± 0.19	−0.04, 0.12	0.346
	Control	22.88 ± 1.38	22.91 ± 1.39	0.02 ± 0.13	−0.05, 0.09	0.473

BU II: Barrett Universal II; IOL: intraocular lens; PACG: primary angle-closure glaucoma; SD: standard deviation.